Results 201 to 210 of about 72,739 (306)
Bladder sarcomatoid carcinoma and giant cell carcinoma without recurrence after robot-assisted radical cystectomy: A case report. [PDF]
Taniguchi T +8 more
europepmc +1 more source
ABSTRACT Blood‐based liquid biopsies hold transformative potential for non‐invasive cancer management, but current approaches relying on rare circulating tumor components limit their broad clinical utility. Platelets, abundant in blood and mediating diverse cancer‐associated responses, represent a compelling yet largely unexplored alternative.
Yan Ma +28 more
wiley +1 more source
Primary Mid-ureter Squamous Cell Carcinoma: A Diagnostic Conundrum in the Absence of Traditional Risk Factors. [PDF]
Masood S, Caratella S, Babu A.
europepmc +1 more source
ABSTRACT Tumor immune escape is a major barrier to durable cancer immunotherapy, as advanced malignancies create a tumor microenvironment (TME) that preferentially exhausts and disables T cell responses. While most approved cell therapies are T cell‐based, this limitation motivates the exploration of an alternative effector cell platform.
Tereza Kochs +4 more
wiley +1 more source
Differential HER2 Expression Across Feline Nasal Carcinoma and Its Relationship with Proliferation and p53 Status. [PDF]
Anjomanibenisi M +4 more
europepmc +1 more source
This study reports a novel rationally‐designed optical nanoprobe based on dumbbell‐shaped mesoporous silica‐coated gold nanorods, loaded with rare‐earth oxides, photosensitizers, and tumor‐targeted peptides, enabling plasmonic‐enhanced multimodal imaging and PTT‐PDT synergy.
Baikang Zhuang +12 more
wiley +1 more source
Incidental renal pelvis and ureteral verrucous carcinoma: A case report and literature review. [PDF]
Yang Z +7 more
europepmc +1 more source

